Logo Light ModeLogo Dark Mode
Why Subscribe?About UsAccreditationLearning Hub CentralLive EventsBlog

Learning Hub Central

Loading…

Contact Us

info@meccinc.com
(305) 663-1628
MEC LogoMEC MedPro LogoMEC Series LogoGlobal Meetings Logo

© 2026 MyMedFlix, All Rights Reserved.

Powered By CMEGenius™
Privacy PolicyTerms and ConditionsCancellation and Refund PolicyAI Disclosure

Learning Hub Central

Filter by title, faculty, or specialty to find the course you're looking for.

SpecialtyThoracic(20 courses)
All specialties

Thoracic

20 courses

2026 NOSCM | Bispecifics and ADCs Making Noise in NSCLC

2026 NOSCM | Bispecifics and ADCs Making Noise in NSCLC

0.00 Credits
1 Chapter
Thoracic
Free
2026 NOSCM | KRAS and BRAF Therapeutic Advances in NSCLC

2026 NOSCM | KRAS and BRAF Therapeutic Advances in NSCLC

0.00 Credits
1 Chapter
Thoracic
Free
2026 NOSCM | Updates on ROS-1 and HER2 Mutated NSCLC Tumors

2026 NOSCM | Updates on ROS-1 and HER2 Mutated NSCLC Tumors

0.00 Credits
1 Chapter
Thoracic
Free
2026 NOSCM | Advancing Therapy for EGFR and ALK Mutated NSCLC Tumors

2026 NOSCM | Advancing Therapy for EGFR and ALK Mutated NSCLC Tumors

0.00 Credits
1 Chapter
Thoracic
Free
2026 NOSCM | Unmet Needs in The Management of Unresectable Stage III NSCLC

2026 NOSCM | Unmet Needs in The Management of Unresectable Stage III NSCLC

0.00 Credits
1 Chapter
Thoracic
Free
2026 NOSCM | Can We Cure Small Cell Lung Cancer?

2026 NOSCM | Can We Cure Small Cell Lung Cancer?

0.00 Credits
1 Chapter
Thoracic
Free
2026 NOSCM | Is SBRT Appropriate in Oligometastatic NSCLC? If Yes, When and How?

2026 NOSCM | Is SBRT Appropriate in Oligometastatic NSCLC? If Yes, When and How?

0.00 Credits
1 Chapter
Thoracic
Free
2026 NOSCM | Selecting The Best Immunotherapy Option in First Line Metastatic NSCLC

2026 NOSCM | Selecting The Best Immunotherapy Option in First Line Metastatic NSCLC

0.00 Credits
1 Chapter
Thoracic
Free
2026 NOSCM | Perioperative vs Adjuvant Therapy in NSCLC

2026 NOSCM | Perioperative vs Adjuvant Therapy in NSCLC

0.00 Credits
1 Chapter
Thoracic
Free
2026 NOSCM | Biomarkers of Novel Therapies: TROP2 and Others Antibody-drug Conjugate

2026 NOSCM | Biomarkers of Novel Therapies: TROP2 and Others Antibody-drug Conjugate

0.00 Credits
1 Chapter
Thoracic
Free
2026 MTTB | Session 9: Small Cell Lung Cancer: Limited and Advanced Stage

2026 MTTB | Session 9: Small Cell Lung Cancer: Limited and Advanced Stage

0.00 Credits
1 Chapter
Thoracic
Free
2026 MTTB | Session 8: Managing Oligoprogressive Disease

2026 MTTB | Session 8: Managing Oligoprogressive Disease

0.00 Credits
1 Chapter
Thoracic
Free
2026 MTTB | Session 7: ADCs in Advanced NSCLC

2026 MTTB | Session 7: ADCs in Advanced NSCLC

0.00 Credits
1 Chapter
Thoracic
Free
2026 MTTB | Session 6: 1st-Line Immunotherapy, Advanced Stage

2026 MTTB | Session 6: 1st-Line Immunotherapy, Advanced Stage

0.00 Credits
1 Chapter
Thoracic
Free
2026 MTTB | Session 5: Molecular Testing in Advanced NSCLC: Other Oncogene Drivers

2026 MTTB | Session 5: Molecular Testing in Advanced NSCLC: Other Oncogene Drivers

0.00 Credits
1 Chapter
Thoracic
Free
2026 MTTB | Session 4: ALK and ROS1+ NSCLC

2026 MTTB | Session 4: ALK and ROS1+ NSCLC

0.00 Credits
1 Chapter
Thoracic
Free
2026 MTTB | Session 3: EGFR-mutated NSCLC

2026 MTTB | Session 3: EGFR-mutated NSCLC

0.00 Credits
1 Chapter
Thoracic
Free
2026 MTTB | Session 2: Unresectable Stage III NSCLC

2026 MTTB | Session 2: Unresectable Stage III NSCLC

0.00 Credits
1 Chapter
Thoracic
Free
2026 MTTB | Session 1: Neo-Adjuvant & Adjuvant Therapy of NSCLC

2026 MTTB | Session 1: Neo-Adjuvant & Adjuvant Therapy of NSCLC

0.00 Credits
1 Chapter
Thoracic
Free
Thoracic Oncology Session

Thoracic Oncology Session

0.00 Credits
1 Chapter
Thoracic
Free

Contact Us

info@meccinc.com
(305) 663-1628
MEC LogoMEC MedPro LogoMEC Series LogoGlobal Meetings Logo

© 2026 MyMedFlix, All Rights Reserved.

Powered By CMEGenius™
Privacy PolicyTerms and ConditionsCancellation and Refund PolicyAI Disclosure